{"entity":{"type":"insider","cik":"0001838112","url":"/insider/0001838112","json_url":"/insider/0001838112.json","name":"Mancini Marianna","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":9,"first":"2023-03-30","last":"2026-07-29","span_basis":"filed_date"},"name_variants":[{"name":"Mancini Marianna","source":"filing","n_filings":9,"first_seen":"2023-03-30","last_seen":"2026-07-29"}],"transactions":[{"id":5887496,"accession":"0001193125-26-324446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-324446","line_url":"/filing/0001193125-26-324446#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18217.0,"shares_display":"18,217","price_per_share":33.4652,"price_display":"33.47","price_state":"stated","total_value":609635.5484,"total_display":"609,635.55","total_whole":"609,636","shares_owned_after":422760.0,"shares_owned_after_display":"422,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-29","filed_date":"2026-07-29","scope":"insider"},{"id":5978061,"accession":"0001193125-26-003115","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-003115","line_url":"/filing/0001193125-26-003115","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57661.0,"shares_display":"57,661","price_per_share":32.975586805639864,"price_display":"32.98","price_state":"stated","total_value":1901405.3108,"total_display":"1,901,405.31","total_whole":"1,901,405","shares_owned_after":434890.0,"shares_owned_after_display":"434,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider","n_lines":4},{"id":5143257,"accession":"0001193125-25-254304","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-254304","line_url":"/filing/0001193125-25-254304#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6185.0,"shares_display":"6,185","price_per_share":35.0027,"price_display":"35.00","price_state":"stated","total_value":216491.6995,"total_display":"216,491.70","total_whole":"216,492","shares_owned_after":382467.0,"shares_owned_after_display":"382,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-28","scope":"insider"},{"id":4584791,"accession":"0000950170-25-093791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-093791","line_url":"/filing/0000950170-25-093791#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4266.0,"shares_display":"4,266","price_per_share":27.7714,"price_display":"27.77","price_state":"stated","total_value":118472.7924,"total_display":"118,472.79","total_whole":"118,473","shares_owned_after":377535.0,"shares_owned_after_display":"377,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-03","filed_date":"2025-07-03","scope":"insider"},{"id":4832185,"accession":"0000950170-25-002486","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-002486","line_url":"/filing/0000950170-25-002486","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54215.0,"shares_display":"54,215","price_per_share":42.74830064557779,"price_display":"42.75","price_state":"stated","total_value":2317599.1195,"total_display":"2,317,599.12","total_whole":"2,317,599","shares_owned_after":379234.0,"shares_owned_after_display":"379,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-06","scope":"insider","n_lines":2},{"id":2827649,"accession":"0000950170-24-088537","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-088537","line_url":"/filing/0000950170-24-088537","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18026.0,"shares_display":"18,026","price_per_share":57.13480306224343,"price_display":"57.13","price_state":"stated","total_value":1029911.96,"total_display":"1,029,911.96","total_whole":"1,029,912","shares_owned_after":365471.0,"shares_owned_after_display":"365,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-30","filed_date":"2024-07-31","scope":"insider","n_lines":2},{"id":2320782,"accession":"0001209191-24-005486","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-24-005486","line_url":"/filing/0001209191-24-005486","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":281425.0,"shares_display":"281,425","price_per_share":78.65851933481389,"price_display":"78.66","price_state":"stated","total_value":22136473.8038,"total_display":"22,136,473.80","total_whole":"22,136,474","shares_owned_after":354756.0,"shares_owned_after_display":"354,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-02","scope":"insider","n_lines":5},{"id":8072243,"accession":"0001209191-23-024723","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024723","line_url":"/filing/0001209191-23-024723#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":287763.0,"shares_owned_after_display":"287,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-18","scope":"insider"},{"id":8042059,"accession":"0001209191-23-021743","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-23-021743","line_url":"/filing/0001209191-23-021743#line-11","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41242.0,"shares_display":"41,242","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":659872.0,"total_display":"659,872.00","total_whole":"659,872","shares_owned_after":261895.0,"shares_owned_after_display":"261,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-30","scope":"insider"},{"id":8042052,"accession":"0001209191-23-021743","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-23-021743","line_url":"/filing/0001209191-23-021743#line-9","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001838112","owner_name":"Mancini Marianna","owner_display_name":"Mancini Marianna","owner_url":"/insider/0001838112","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196563.0,"shares_display":"196,563","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":2948445.0,"total_display":"2,948,445.00","total_whole":"2,948,445","shares_owned_after":288137.0,"shares_owned_after_display":"288,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-03-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001607678","name":"Viking Therapeutics, Inc.","url":"/issuer/0001607678","role":"Officer (Chief Operating Officer)","n_filings":9,"first_seen":"2023-03-30","last_seen":"2026-07-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001838112","retrieved_at":"2026-08-23T09:14:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}